Satellos Bioscience Inc · TSX:MSCL
Qiming U.S. Healthcare Fund III, L.P. reported a 8.30% stake in Satellos Bioscience Inc (Schedule 13G)
Event Mar 31, 2026 · Filed May 12, 2026
Qiming U.S. Healthcare Fund III, L.P. reported a 8.30% stake in Satellos Bioscience Inc, 1,725,247 shares, as a passive investor on Mar 31, 2026. Filed May 12, 2026 (Schedule 13G).
- Stake
- 8.30%
- Shares
- 1,725,247
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Qiming U.S. Healthcare Fund III, L.P. | 8.30% | 1,725,247 |
| Qiming U.S. Healthcare GP III, LLC | 8.30% | 1,725,247 |
| Mark McDade | 8.30% | 1,725,247 |
| GARY E RIESCHEL | 8.30% | 1,725,247 |